[ad_1] The historic stock-market rally has shown few signs of stopping since October — with…
Novel Coronaviruses
-
-
STOCK MARKET
Expanding the child tax credit could come from axing this fraud ‘magnet’
by userby user[ad_1] Congress is considering a new bipartisan tax package that would expand the child tax…
-
STOCK MARKET
Intuitive Surgical leads S&P 500 gainers after guidance that handily topped analyst estimates
by userby user[ad_1] Shares of Intuitive Surgical Inc. rallied 9.5% Wednesday to lead S&P 500 gainers, after the…
-
STOCK MARKET
Sharing COVID therapy secrets is a Trojan horse that would gut U.S. biotech
by userby user[ad_1] “It’s time for the Biden administration to nix this misguided IP waiver once and…
-
STOCK MARKET
Crude oil sees first real ‘death cross’ since the pandemic plunge of early 2020
by userby user[ad_1] Charts of crude-oil futures have just flashed a bearish signal the likes of which…
-
STOCK MARKET
My friend was scared to death of COVID. I told him to get a colonoscopy.
by userby user[ad_1] When I came down with COVID-19 recently, I heard from a concerned friend who…
-
STOCK MARKET
New York City wants its residents to live longer and healthier, and the rest of the country may follow.
by userby user[ad_1] New York City is launching a broad public health campaign to increase longevity to…
-
STOCK MARKET
Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
by userby user[ad_1] Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering…
-
STOCK MARKET
Pfizer to more than double price of its COVID antiviral once drug moves to commercial market
by userby user[ad_1] Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral…
-
[ad_1] Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination…